Furthermore, the combination of PD325901 and rapamycin treatment of mice bearing orthotopically-transplanted PCSCs displaying conditional Pten loss and oncogenic Kras(G12D) expression showed reduced primary tumor burden compared to PD325901 treatment alone, and ablated their ability for macrometastatic colonization [120]. This evidence concerns the gene KRAS and neoplasm.